Ective cohort study. Med Sci Monit, 2012; 18(four): CR215?four 44. Wintergerst ES, Maggini S, Hornig DH: Immune-enhancing role of vitamin C and zinc and impact on clinical circumstances. Ann Nutr Metab, 2006; 50: 85?four 45. Wintergerst ES, Maggini S, Hornig DH: Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab, 2006; 50: 85?four 46. Gerber WF: Impact of ascorbic acid, sodium salicylate and caffeine on the serum interferon level in response to viral infection. Pharmacology, 1975; 13: 228?3 47. Karpinska T, Kawecki Z, Kandefer-Szerszen M: The influence of ultraviolet irradiation, L-ascorbic acid and calcium chloride on the induction of interferon in human embryo fibroblasts. Arch Immunol Ther Exp (Warsz), 1982; 30: 33?48. Mandl J, Szarka A, Banhegyi G: Vitamin C: update on physiology and pharmacology. Br J Pharmacol, 2009; 157(7): 1097?10 49. Mikirova NA, Casciari JJ, Taylor PR, Taylor P: Effect of high-dose intravenous vitamin C on inflammation in cancer sufferers. J Transl Med, 2012; ten: 189 50.3-Azidopropylamine Purity Mikirova NA, Rogers AM, Casciari JJ, Taylor P: Impact of high dose intravenous ascorbic acid around the level of inflammation in patients with rheumatoid arthritis.Formula of Cholic acid Modern Res Infl, 2012; 1(2): 26?two 51.PMID:24633055 Furuya A, Uozaki M, Yamasaki H et al: Antiviral effects of ascorbic acid and dehydroascorbic acids in vitro. Int J Mol Med, 2008; 22: 541?5 52. White LA, Freeman CY, Forrester BD, Chappell WA: In vitro impact of ascorbic acid on infectivity of herpeviruses and paramyxoviruses. J Clin Microbiol, 1986; 24(four): 527?1 53. Murata A, Oyadomari R, Ohashi T, Kitagawa K: Mechanism of inactivation of bacteriophage deltaA containing single-stranded DNA by ascorbic acid. J Nutr Sci Vitaminol (Tokyo), 1975; 21: 261?9 54. Bissell MJ, Hatie C, Farson DA et al: Ascorbic acid inhibits replication and infectivity of avian RNA tumor virus. Cell Biol, 1980; 77(5): 2711?five 55. Johannsen EC, Schooley RT, Kaye KM: Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R (eds.), Principles and Practive of Infectious Diseases. 6th ed. vol two. Philadelphia (PA): Churchill Livingstone, 2005; 1801?1 56. Torre D, Tambini R: Acyclovir for remedy of infectious mononucleosis: a meta-analysis. Scand J Infect Dis, 1999; 31: 543?7 57. Tynell E, Aurelius E, Brandell A et al: Acyclovir and prednisolone remedy of acute infectious mononucleosis: a multicenter, double-blind, placebocontrolled study. J Infect Dis, 1996; 174(two): 324?1 58. Yongjun Y, Maguire TG, Alwine JC: Human cytomegalovirus activates glucose transporter 4 expression to enhance glucose update in the course of infection. J Virol, 2011; 85(4): 1573?0 59. Rose RC: Transport of ascorbic acid along with other water-soluble vitamins. Biochim Biophys Acta, 1988; 947(2): 335?6 60. Vera JC, Rivas CI, Fischbarg J, Golde DW: Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature, 1993; 364: 79?two 61. Vera JC, Rivas CI, Velasquez FV et al: Resolution from the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid. J Biol Chem, 1995; 270(40): 23706?2 62. Gunville CF, Mourani PM, Ginde AA: The Role of Vitamin D in Prevention and Remedy of Infection. Inflamm Allergy Drug Targets, 2013; 12(4): 239?five 63. Cantorna MT, Yu S, Bruce D: The paradoxical effects of vitamin D on variety 1 mediated immunity. Mol Elements Med, 2008; 29: 369?five 64. Beardb JA, Beardena A, Strikera R: Vitamin D as well as the anti-viral state. J Clin Viro.